HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lin Cheng Selected Research

isoliensinine

1/2022Isoliensinine induces cervical cancer cell cycle arrest and apoptosis by inhibiting the AKT/GSK3α pathway.
1/2021Isoliensinine: A Natural Compound with "Drug-Like" Potential.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lin Cheng Research Topics

Disease

104Neoplasms (Cancer)
01/2022 - 08/2009
42Breast Neoplasms (Breast Cancer)
01/2022 - 01/2005
20Inflammation (Inflammations)
12/2022 - 12/2008
18COVID-19
12/2022 - 01/2020
16Infections
06/2022 - 01/2011
16Neoplasm Metastasis (Metastasis)
01/2022 - 09/2012
10Lung Neoplasms (Lung Cancer)
01/2022 - 12/2011
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2013
9Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2013
8Thyroid Neoplasms (Thyroid Cancer)
04/2022 - 01/2019
8Stroke (Strokes)
10/2021 - 09/2015
8Glioblastoma (Glioblastoma Multiforme)
02/2021 - 09/2010
7Glioma (Gliomas)
01/2017 - 07/2010
6Carcinogenesis
02/2021 - 01/2013
5Cognitive Dysfunction
12/2022 - 01/2020
5Virus Diseases (Viral Diseases)
01/2022 - 08/2013
5Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2014
5Rheumatoid Arthritis
10/2021 - 04/2017
5Wounds and Injuries (Trauma)
08/2021 - 06/2016
5Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020 - 09/2015
4Cicatrix (Scar)
03/2022 - 12/2015
4Disease Progression
03/2022 - 11/2012
4Leukemia
01/2022 - 01/2012
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2013
4Fibrosis (Cirrhosis)
12/2021 - 03/2016
4Retinal Degeneration
11/2021 - 09/2016
4Carcinoma (Carcinomatosis)
01/2021 - 09/2004
4Type 2 Diabetes Mellitus (MODY)
01/2021 - 03/2016
4Hepatocellular Carcinoma (Hepatoma)
05/2020 - 09/2012
4Colonic Neoplasms (Colon Cancer)
01/2019 - 08/2012
4Ischemia
06/2018 - 08/2007
3Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 08/2020
3medullary Thyroid cancer
04/2022 - 01/2019
3Anaplastic Thyroid Carcinoma
04/2022 - 01/2019
3Pain (Aches)
01/2022 - 01/2016
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2018
3Lymphoma (Lymphomas)
01/2022 - 01/2019
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 11/2014
3Rupture
01/2022 - 12/2010
3Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 01/2012
3Viremia
01/2021 - 01/2018
3Necrosis
12/2020 - 01/2017
3Neuroblastoma
11/2020 - 03/2014
3Colitis-Associated Neoplasms
03/2020 - 01/2020
3Hypoxia (Hypoxemia)
01/2020 - 08/2007
3Papillary Thyroid Cancer
01/2020 - 01/2013
3Spinal Cord Injuries (Spinal Cord Injury)
12/2019 - 10/2014
3Brain Injuries (Brain Injury)
10/2019 - 09/2015

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2008
33Biomarkers (Surrogate Marker)IBA
05/2022 - 09/2010
18Pharmaceutical PreparationsIBA
01/2022 - 04/2007
17Messenger RNA (mRNA)IBA
04/2022 - 03/2008
12CytokinesIBA
04/2022 - 01/2014
11VaccinesIBA
04/2022 - 10/2013
11MicroRNAs (MicroRNA)IBA
01/2022 - 08/2012
10Biological ProductsIBA
05/2022 - 10/2008
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 12/2008
7Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2011
7AntibodiesIBA
01/2022 - 10/2013
7Estrogen ReceptorsIBA
12/2021 - 10/2007
6Monoclonal AntibodiesIBA
01/2022 - 01/2015
6Liposomes (Liposome)IBA
01/2022 - 08/2012
6Indicators and Reagents (Reagents)IBA
01/2022 - 01/2005
6AntigensIBA
01/2022 - 10/2013
5Tyrosine Kinase InhibitorsIBA
04/2022 - 12/2011
5LipidsIBA
01/2022 - 11/2016
5Chimeric Antigen ReceptorsIBA
01/2022 - 01/2019
5Long Noncoding RNAIBA
01/2022 - 01/2016
5Progesterone Receptors (Progesterone Receptor)IBA
12/2021 - 10/2007
5Therapeutic UsesIBA
01/2021 - 06/2014
5SaponinsIBA
10/2018 - 01/2014
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
4Phosphotransferases (Kinase)IBA
01/2021 - 03/2011
4Oxygen (Dioxygen)IBA
01/2020 - 06/2018
4RhamnoseIBA
10/2018 - 01/2014
4TriterpenesIBA
10/2018 - 01/2014
3Allopurinol (Remid)FDA LinkGeneric
03/2022 - 12/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 10/2014
3Interleukin-18 (Interleukin 18)IBA
03/2022 - 01/2014
3IronIBA
01/2022 - 01/2019
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2015
3Peptides (Polypeptides)IBA
01/2022 - 01/2019
3Voriconazole (Vfend)FDA LinkGeneric
01/2022 - 01/2020
3CateninsIBA
01/2022 - 12/2013
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
07/2021 - 01/2017
3CalciumIBA
05/2021 - 01/2021
3Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 01/2018
3Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 03/2016
3Neutralizing AntibodiesIBA
01/2021 - 01/2018
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2020 - 01/2014
3Aromatic HydrocarbonsIBA
01/2020 - 04/2017
3Histones (Histone)IBA
01/2020 - 01/2018
3Neuroprotective AgentsIBA
11/2019 - 11/2014

Therapy/Procedure

55Therapeutics
01/2022 - 09/2004
18Drug Therapy (Chemotherapy)
01/2022 - 10/2007
13Immunotherapy
01/2022 - 01/2014
5Transplantation
05/2022 - 09/2015
5Neoadjuvant Therapy
01/2021 - 10/2007
4Radiotherapy
01/2019 - 03/2006
3Lasers (Laser)
12/2021 - 01/2015